DK1326502T3 - Fremgangsmåde til fremstilling af en blanding, som kan granuleres, samt carnitin-magnesium-hydroxycitrat - Google Patents
Fremgangsmåde til fremstilling af en blanding, som kan granuleres, samt carnitin-magnesium-hydroxycitratInfo
- Publication number
- DK1326502T3 DK1326502T3 DK01969667T DK01969667T DK1326502T3 DK 1326502 T3 DK1326502 T3 DK 1326502T3 DK 01969667 T DK01969667 T DK 01969667T DK 01969667 T DK01969667 T DK 01969667T DK 1326502 T3 DK1326502 T3 DK 1326502T3
- Authority
- DK
- Denmark
- Prior art keywords
- granulable
- mixture
- preparation
- magnesium hydroxy
- carnitine magnesium
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 title 1
- CKXIOUQWHVIOLK-UHFFFAOYSA-L C(CC(O)(C(=O)[O-])CC(=O)[O-])(=O)OO.[Mg+2] Chemical compound C(CC(O)(C(=O)[O-])CC(=O)[O-])(=O)OO.[Mg+2] CKXIOUQWHVIOLK-UHFFFAOYSA-L 0.000 title 1
- 229960004203 carnitine Drugs 0.000 title 1
- ZMJBYMUCKBYSCP-UHFFFAOYSA-N Hydroxycitric acid Chemical compound OC(=O)C(O)C(O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-UHFFFAOYSA-N 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- 229960005336 magnesium citrate Drugs 0.000 abstract 1
- 239000004337 magnesium citrate Substances 0.000 abstract 1
- 229940091250 magnesium supplement Drugs 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00118656 | 2000-08-29 | ||
PCT/EP2001/009962 WO2002017735A2 (fr) | 2000-08-29 | 2001-08-29 | Procede de fabrication d'un melange pouvant etre granule et hydroxycitrate de carnitine et de magnesium |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1326502T3 true DK1326502T3 (da) | 2005-08-22 |
Family
ID=8169680
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01969667T DK1326502T3 (da) | 2000-08-29 | 2001-08-29 | Fremgangsmåde til fremstilling af en blanding, som kan granuleres, samt carnitin-magnesium-hydroxycitrat |
Country Status (10)
Country | Link |
---|---|
US (2) | US20030176514A1 (fr) |
EP (1) | EP1326502B1 (fr) |
JP (1) | JP4668513B2 (fr) |
AT (1) | ATE295690T1 (fr) |
AU (1) | AU2001289849A1 (fr) |
DE (1) | DE50106272D1 (fr) |
DK (1) | DK1326502T3 (fr) |
ES (1) | ES2242770T3 (fr) |
PT (1) | PT1326502E (fr) |
WO (1) | WO2002017735A2 (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20030831A1 (it) | 2003-04-22 | 2004-10-23 | Laboratorio Chimico Int Spa | Sale basico dell'acido tiottico con la l-carnitina. |
CA2538929A1 (fr) * | 2003-09-11 | 2005-03-24 | Glykon Technologies Group, Llc | Administration enterique d'acide (-)-hydroxycitrique |
JP4754484B2 (ja) * | 2004-03-18 | 2011-08-24 | 田辺三菱製薬株式会社 | うつ様症状改善剤 |
US20050215640A1 (en) * | 2004-03-26 | 2005-09-29 | Baxter Jeffrey H | HMB compositions and uses thereof |
BRPI0612611A2 (pt) | 2005-07-05 | 2010-12-07 | Lonza Ag | processo de secagem por pulverização para produzir um pó ou granulado seco de carnitina |
US20070072910A1 (en) * | 2005-09-29 | 2007-03-29 | Smith Michael L | Compositions and methods for lowering plasma concentrations of low density lipoproteins in humans |
ES2548305T3 (es) * | 2005-12-19 | 2015-10-15 | Abbott Laboratories | Uso de beta-hidroxi-beta-metilbutirato para tratar el asma |
CN101209975B (zh) * | 2006-12-29 | 2010-12-01 | 沈阳科硕营养科技有限公司 | 左旋肉碱富马酸钙及其制备方法与用途 |
EP2206440A1 (fr) * | 2008-12-24 | 2010-07-14 | Taminco | Processus de préparation d'une poudre à écoulement libre d'un composé d'ammoniac quaternaire déliquescent |
US9693577B2 (en) | 2010-01-29 | 2017-07-04 | Abbott Laboratories | Method of preparing a nutritional powder comprising spray dried HMB |
SG182812A1 (en) | 2010-01-29 | 2012-09-27 | Abbott Lab | Nutritional emulsions comprising calcium hmb |
US8916217B2 (en) | 2010-01-29 | 2014-12-23 | Abbott Laboratories | Aseptically packaged nutritional liquids comprising HMB |
TWI526161B (zh) | 2010-06-10 | 2016-03-21 | 亞培公司 | 包含鈣hmb及可溶性蛋白質之實質上透明營養液 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1153640A (en) * | 1967-04-10 | 1969-05-29 | Soc D Etudes Prod Chimique | A Carnitin Salt |
DE3463261D1 (en) * | 1983-12-28 | 1987-05-27 | Sigma Tau Ind Farmaceuti | Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same |
IT1172394B (it) * | 1983-12-28 | 1987-06-18 | Sigma Tau Ind Farmaceuti | Sali della l-carnitina e di alcuni alcanoil derivati della l-carnitina e procedimento per la loro preparazione |
CA2018137C (fr) * | 1989-06-14 | 2000-01-11 | Thomas Scholl | Citrate magnesique de l-carnitine |
US5780451A (en) * | 1994-04-01 | 1998-07-14 | Abbott Laboratories | Nutritional product for a person having ulcerative colitis |
WO1996036585A1 (fr) | 1995-05-15 | 1996-11-21 | Sabinsa Corporation | Nouveau procede de production d'acide hydroxy citrique de potassium et compositions contenant l'acide hydroxy citrique de potassium |
IT1276253B1 (it) * | 1995-12-15 | 1997-10-27 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi |
US5817329A (en) * | 1997-02-28 | 1998-10-06 | Gardiner; Paul T. | Nutritional supplement for increased muscle size and strength for body builders |
IT1291134B1 (it) * | 1997-04-08 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizioni solide atte alla somministrazione orale comprendenti una alcanoil l-carnitina magnesio citrato |
IT1290600B1 (it) * | 1997-04-30 | 1998-12-10 | Sigma Tau Ind Farmaceuti | Composizioni solide atte alla somministrazione orale comprendenti l-carnitina e alcanoil l-carnitine magnesio fumarato |
-
2001
- 2001-08-29 AU AU2001289849A patent/AU2001289849A1/en not_active Abandoned
- 2001-08-29 US US10/362,730 patent/US20030176514A1/en not_active Abandoned
- 2001-08-29 DE DE50106272T patent/DE50106272D1/de not_active Expired - Lifetime
- 2001-08-29 JP JP2002522720A patent/JP4668513B2/ja not_active Expired - Fee Related
- 2001-08-29 EP EP01969667A patent/EP1326502B1/fr not_active Expired - Lifetime
- 2001-08-29 DK DK01969667T patent/DK1326502T3/da active
- 2001-08-29 WO PCT/EP2001/009962 patent/WO2002017735A2/fr active IP Right Grant
- 2001-08-29 PT PT01969667T patent/PT1326502E/pt unknown
- 2001-08-29 ES ES01969667T patent/ES2242770T3/es not_active Expired - Lifetime
- 2001-08-29 AT AT01969667T patent/ATE295690T1/de active
-
2004
- 2004-02-25 US US10/785,013 patent/US7230131B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20030176514A1 (en) | 2003-09-18 |
US20040167219A1 (en) | 2004-08-26 |
JP4668513B2 (ja) | 2011-04-13 |
ATE295690T1 (de) | 2005-06-15 |
AU2001289849A1 (en) | 2002-03-13 |
WO2002017735A2 (fr) | 2002-03-07 |
PT1326502E (pt) | 2005-09-30 |
DE50106272D1 (de) | 2005-06-23 |
ES2242770T3 (es) | 2005-11-16 |
EP1326502B1 (fr) | 2005-05-18 |
US7230131B2 (en) | 2007-06-12 |
JP2004507479A (ja) | 2004-03-11 |
EP1326502A2 (fr) | 2003-07-16 |
WO2002017735A3 (fr) | 2002-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1326502T3 (da) | Fremgangsmåde til fremstilling af en blanding, som kan granuleres, samt carnitin-magnesium-hydroxycitrat | |
HU9300685D0 (en) | Method for producing crystallic momethazone-furoate-monohydrate and pharmaceutical preparatives containing it | |
MY139206A (en) | Pharmaceuticals compositions comprising mycophenolic acid or mycophenolate salt | |
DK0542669T3 (da) | Fremgangsmåde til fremstilling af pigmenter, især fluorescerende pigmenter. | |
IS5600A (is) | Aðferð til framleiðslu á vernduðu 4-amínómetýl-pýrrólidín-3-óni. | |
HK1073295A1 (en) | Acetyl l-carnitine acid fumarate and process for preparing the same | |
ATE253037T1 (de) | Verfahren zur racematspaltung von tramadol | |
DK1325022T3 (da) | Fremgangsmåde til fremstilling af 21-hydroxy-6,19-oxidoprogesteron (21OH-6OP) | |
ATE233725T1 (de) | Verfahren zum herstellen von methylmethacrylat | |
TR199700174A2 (tr) | Asimetrik 4,6-bis(ariloksi)pirimidin bilesiklerinin hazirlanmasi icin proses. | |
JPS5225037A (en) | Carcinostatic agent | |
JPS51130135A (en) | Information processing system | |
DK1181247T3 (da) | Pressede produkter af ikke-sammenbagende salt | |
JPS5222586A (en) | Method for protective treatment of fluorescent substance | |
JPS51115989A (en) | Process for preparing creatinine amide hydrolase | |
JPS5236951A (en) | Computer system | |
FR2663692B1 (fr) | Procede d'assemblage, notamment du bois, utilisant des inserts d'ancrage. | |
JPS523431A (en) | Video correcting method | |
JPS5210250A (en) | Preparations of cholesta-5,23,24-triene- 3beta -ols | |
JPS5219183A (en) | Electrodialysis process | |
JPS51139680A (en) | Method for purifing enzyme | |
DK0891979T3 (da) | Krystallinsk form af N,N-dimethyl-3-amino-1-hydroxypropan-1,1-diphosphonsyre-mononatrium-monohydrat og fremgangsmåde til fremstilling heraf | |
TH54388A (th) | กรรมวิธีสำหรับการเตรียมดิสโคเดอร์โมไลด์แลแอนาลอกของสิ่งนี้ | |
DK1196415T3 (da) | Fremgangsmåde til fremstilling af lysergsyre | |
JPS51111055A (en) | Semiconductor manufacturing method |